CEO Dominik Witzigmann Co-Organizes CRS Symposium on LNP-RNA Therapeutics

Apr 9, 2022

NanoVation Therapeutics™ CEO & Co-Founder Dr. Dominik Witzigmann co-organized a 2-day virtual symposium on “LNP-RNA Therapeutics: Beyond COVID” alongside Dr. Juliana Haggerty, head of Centre of Excellence – Lipid NanoParticle at CPI.

Together they hosted talks from various experts in their fields covering topics such as Delivery Platform Technologies – including a talk from NanoVation CSO Dr. Jayesh Kulkarni – Manufacturing/New Technologies, and Cell Therapies.